Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Treosulfan vs Busulfan conditioning for pediatric HSCT in non-malignant diseases
NCT02349906Phase 2Completed
- Sponsor
- medac GmbH
- Start
- Apr 2015
- Primary completion
- May 2020
- Modality
- DNA Intercalators/Alkylators
- Countries
- 4
01
Overview
A Phase 2 trial of treosulfan, sponsored by medac GmbH. Started Apr 2015; status: completed.
02
Drugs
treosulfan
Beyond the preview
Go deeper on NCT02349906.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02349906.